Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.
Revenue of Sanofi India Limited (SANOFI.NS)
Revenue in 2023 (TTM): $337.79 M
According to Sanofi India Limited's latest financial reports the company's current revenue (TTM) is $337.79 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Sanofi India Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $337.79 M | $193.41 M | $105.07 M | $100.17 M | $71.43 M |
| 2022 | $328.2 M | $187.25 M | $107.57 M | $102.4 M | $73.53 M |
| 2021 | $346.5 M | $191.67 M | $157.11 M | $149 M | $111.89 M |
| 2020 | $339.89 M | $191.37 M | $90.19 M | $80.23 M | $56.58 M |
| 2019 | $357.07 M | $197.43 M | $82.91 M | $71.07 M | $49.07 M |
| 2018 | $324.89 M | $189.13 M | $84.42 M | $72.25 M | $45.09 M |
| 2017 | $292.64 M | $170.38 M | $73.08 M | $60.97 M | $38.62 M |
| 2016 | $277.47 M | $151.09 M | $70.99 M | $55.22 M | $35.19 M |
| 2015 | $257.8 M | $137.55 M | $60.47 M | $47.04 M | $38.09 M |
| 2014 | $232.74 M | $117.09 M | $42.15 M | $36.26 M | $31.23 M |
| 2013 | $213.38 M | $116.11 M | $49.26 M | $43.02 M | $31.42 M |
| 2012 | $185.89 M | $98.39 M | $41.65 M | $31.01 M | $20.93 M |
| 2011 | $145.7 M | $72.32 M | $37.34 M | $33.65 M | $22.65 M |
| 2010 | $128.54 M | $64.68 M | $30.06 M | $27.72 M | $18.37 M |
| 2009 | $115.45 M | $58.34 M | $30.67 M | $28.61 M | $18.65 M |
| 2008 | $116.5 M | $60.07 M | $32.95 M | $30.76 M | $19.69 M |
| 2007 | $103.5 M | $53.44 M | $28.07 M | $26.4 M | $17.11 M |
| 2006 | $104.73 M | $53.94 M | $31.24 M | $29.58 M | $20.06 M |
| 2005 | $95.71 M | $51.23 M | $29.72 M | $28.01 M | $17.19 M |
| 2004 | $87.08 M | $47.95 M | $28 M | $26.8 M | $17.59 M |